Portfolio company Stilla Technologies (digital PCR) acquired by Bio-Rad Laboratories for $225M plus up to $50M in milestones.
Stilla Technologies specializes in digital PCR technology, offering systems and assays for precise quantification and analysis in life sciences research
Stilla Technologies specializes in digital PCR technology, offering systems and assays for precise quantification and analysis in life sciences research.